Literature DB >> 6488175

Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia.

J Hilton.   

Abstract

A cyclophosphamide-resistant L1210 cell line has been shown to have unusually high aldehyde dehydrogenase activity. The sensitivity of this cell line to 4-methylcyclophosphamide and phosphoramide mustard in vivo and corresponding sensitivities in vitro indicate that 4-hydroxycyclophosphamide and/or aldophosphamide is the form in which cyclophosphamide reaches these tumor cells in mice and that intracellular aldehyde dehydrogenase activity is an important determinant of cyclophosphamide sensitivity in these leukemia cell lines.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6488175

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  60 in total

1.  Aldehyde dehydrogenase activity in xenografted human brain tumor in nude mice. Preliminary results in human glioma biopsies.

Authors:  V Quemener; J P Moulinoux; C Martin; F Darcel; Y Guegan; J Faivre; G A Quash
Journal:  J Neurooncol       Date:  1990-10       Impact factor: 4.130

2.  Discovery of a novel class of covalent inhibitor for aldehyde dehydrogenases.

Authors:  May Khanna; Che-Hong Chen; Ann Kimble-Hill; Bibek Parajuli; Samantha Perez-Miller; Sulochanadevi Baskaran; Jeewon Kim; Karl Dria; Vasilis Vasiliou; Daria Mochly-Rosen; Thomas D Hurley
Journal:  J Biol Chem       Date:  2011-10-21       Impact factor: 5.157

Review 3.  The role of human aldehyde dehydrogenase in normal and cancer stem cells.

Authors:  Irene Ma; Alison L Allan
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 4.  Stem cell plasticity: a rare cell, not a rare event.

Authors:  Yoon-Young Jang; Saul J Sharkis
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

5.  Mechanisms of resistance to alkylating agents.

Authors:  G Damia; M D'Incalci
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

6.  RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression.

Authors:  Audrey N Jajosky; James E Coad; Jeffrey A Vos; Karen H Martin; Jamie R Senft; Sharon L Wenger; Laura F Gibson
Journal:  Stem Cells Transl Med       Date:  2014-05-22       Impact factor: 6.940

7.  Discovery of a series of aromatic lactones as ALDH1/2-directed inhibitors.

Authors:  Cameron D Buchman; Krishna K Mahalingan; Thomas D Hurley
Journal:  Chem Biol Interact       Date:  2015-01-29       Impact factor: 5.192

8.  Inhibition of the Aldehyde Dehydrogenase 1/2 Family by Psoralen and Coumarin Derivatives.

Authors:  Cameron D Buchman; Thomas D Hurley
Journal:  J Med Chem       Date:  2017-03-06       Impact factor: 7.446

Review 9.  Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages.

Authors:  Robert A Brodsky; Richard J Jones
Journal:  Autoimmunity       Date:  2008-12       Impact factor: 2.815

10.  Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma.

Authors:  Kefeng Wang; Xiaonan Chen; Yunhong Zhan; Weiguo Jiang; Xuefeng Liu; Xia Wang; Bin Wu
Journal:  Med Oncol       Date:  2013-04-13       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.